Two organizers of MIT’s Relay for Life prepare to pass the torch
One thousand students and community members raise more than $85,000 for cancer research at all-night event
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Precision attack on cancer
Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.
How tumors escape
Biologists identify extracellular proteins that help aggressive tumors spread through the body.
A paper diagnostic for cancer
Low-cost urine test developed by MIT engineers amplifies signals from growing tumors to detect disease.
Hitchhiking vaccines boost immunity
New MIT vaccines that catch a ride to immune cell depots could help fight cancer and HIV.
Better RNA interference, inspired by nature
New MIT nanoparticles offer best-ever gene silencing, could help treat liver diseases.
A microchip for metastasis
MIT researchers design a microfluidic platform to see how cancer cells invade specific organs.
New weapon fights drug-resistant tumors
Biologists identify a drug that can help wipe out reservoirs of cancer cells in bone marrow.
Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
New sensor tracks zinc in cells
Shifts in zinc’s location could be exploited for early diagnosis of prostate cancer.
MIT Center for Integrative Synthetic Biology receives five-year NIH grant
Five-year grant will support research on cancer therapy, artificial tissue homeostasis, and infectious diseases.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Resistance is futile
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
One-two punch knocks out aggressive tumors
New nanoparticles weaken tumor-cell defenses, then strike with chemotherapy drug.